[1]
V. G. Viana, “IMPACT OF SEMAGLUTIDE USE ON LEAN MASS AND SARCOPENIA RISK: AN INTEGRATIVE REVIEW OF CLINICAL EVIDENCE”, Editora, pp. 416–427, Feb. 2026, doi: 10.56238/sevened2026.009-036.